HORSHAM, Pa., April 17, 2018 /PRNewswire-PRWeb/ -- Global Clinical and Ancillary Supply Chain leader Ancillare, LP, the
The '40 Under 40' recognizes current and future leaders in the Philadelphia region for their professional excellence, outstanding success, and contributions to their community. Santomauro was selected from more than 400 nominations.
Santomauro was instrumental in defining a singular focus on the clinical and ancillary supply chain industry, and most notably recognized as the driving force behind the Ancillare Turn-Key Operation (A-TKO) end-to-end solution, which has revolutionized how the industry approaches its clinical supply chain. Through this and other business models, Ancillare will continue to remain at the forefront of the global clinical supply chain industry and will continue to have a direct impact on clinical trial operations, timelines, site performance, and ultimately patient experiences.
Ancillare has grown from a start-up organization to a global organization with over 200 employees around the world. Today, eight of the ten top global pharmaceutical companies, three of the five top global biotechnology companies, and the top two clinical research organizations turn to Ancillare to manage their Phase I-IV trial clinical and ancillary supply demands.
"To be named one of the Philadelphia Business Journal's '40 Under 40' is such an honor," said Santomauro. "I am fortunate to have a career that has direct impact on clinical trial operations and the development of innovative therapies for patients around the world."
Active in the local business community as a member of YPO (formerly Young Presidents Organization) Philadelphia Chapter, and a long-time member of the Advisory Council for Entrepreneurship at Cornell University, where Santomauro obtained his Masters of Business Administration and Bachelor of Arts.
Santomauro will be honored at an award ceremony at SugarHouse Casino in Philadelphia on Thursday, May 10.
About Ancillare, LP Ancillare is the only organization of its kind with an exclusive focus on the global clinical and ancillary supply chain. Ancillare arms sponsors of global clinical trials with a customized, end-to-end Ancillare Supply Plan, enabling developers of new therapies to optimize their clinical study supply chains using streamlined processes, extensive global buying power, a vast depot network and proven teams of clinical, procurement, operations, logistics and regulatory experts. Ancillare's Turn-Key Operations (A-TKO) model embraces the complexities and globalization of the clinical and ancillary supply chain by reducing both the overall cost and cycle time of clinical trials, and greatly improving operational efficiency across all levels of the value chain.
Ancillare has supported more than 1,500 clinical trials across 80,000 clinical sites over 100 countries with master depots in United States, United Kingdom, and Singapore, and strategic depots in Argentina, Australia, Brazil, Canada, Chile, China, Colombia, India, Israel, Japan, Korea, Mexico, Panama, Peru, Philippines, Russia, South Africa, Taiwan, and Ukraine. To learn more, visit ancillare.com.
Subscribe to our Free Newsletters!
Lazy eye or amblyopia occurs when sight in one eye is less than the other in early childhood due to ...
Tracheal or windpipe cancer is a rare cancer and its cause is unclear. The most common squamous ...
Tecovirimat can be used to treat smallpox disease in adult and pediatric patients who weigh at ...View All